PRESS RELEASES

Date Title and Summary View
Toggle Summary GlycoMimetics, Inc. to Present New Data on Lead Compounds at International Symposium View HTML
Toggle Summary GlycoMimetics, Inc. Highlights Advances in Lead Drug Candidate for Sickle Cell Patients at International Glycobiology Conference View HTML
Toggle Summary GlycoMimetics, Inc. to Present Results of Lead Candidate in Animal Models of Sickle Cell Disease at American Society of Hematology Annual Meeting View HTML
Toggle Summary GlycoMimetics, Inc. Commences Phase 1 Clinical Trial of Lead Drug Candidate View HTML
Toggle Summary GlycoMimetics, Inc. to Present New Results of Lead Candidate in Additional Animal Models of Sickle Cell Disease at American Society of Hematology Annual Meeting View HTML
Toggle Summary GlycoMimetics, Inc. Completes Phase 1 Clinical Studies of Lead Drug Candidate View HTML
Toggle Summary Dana-Farber Cancer Institute Presents Results of GlycoMimetics’ Lead Drug Candidate in Models of Multiple Myeloma at American Society of Clinical Oncology Annual Meeting View HTML
Toggle Summary Nature Reviews: Drug Discovery Article Describes Design of Glycomimetic Compounds and Newly “Druggable” Disease Targets View HTML
Toggle Summary GlycoMimetics, Inc. Awarded NIH Grant to Study Drug Candidate in Diabetes View HTML
Toggle Summary New Drug to Treat Sickle Cell Crisis Begins Pilot Study in Patients View HTML